Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
Benefits for type 2 diabetes of interrupting prolonged sitting.
Imaging athletes’ hearts during exercise, not at rest.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
Biomarkers that highlight toxic fats in the liver.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.
Find out more
